IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation

Thorax

Volumn 68, Issue 8, 2013, Pages 717-723

  Newcomb, Dawn Catherine ^a   Boswell, Madison G ^a   Reiss, Sara ^a   Zhou, Weisong ^a   Goleniewska, Kasia ^a   Toki, Shinji ^a   Harintho, Melissa T ^a   Lukacs, Nicholas W ^b   Kolls, Jay K ^c   Peebles Jr , R Stokes ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 23P19; MESSENGER RNA; OVALBUMIN; PEPTIDE;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GENE EXPRESSION; IMMUNOSTIMULATION; LUNG HOMOGENATE; LUNG LAVAGE; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; T LYMPHOCYTE;

ALLERGIC LUNG DISEASE; ASTHMA; CYTOKINE BIOLOGY; RESPIRATORY INFECTION;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RNA, MESSENGER;

EID: 84879905689     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202404     Document Type: Article

References (39)

1. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11-year-old children. BMJ 1995;310:1225-9.
2. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-6. (Pubitemid 23306765)
3. Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002;324:763.
4. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005;171:137-41. (Pubitemid 40105412)
5. Peebles RS Jr, Sheller JR, Johnson JE, et al. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice. J Med Virol 1999;57:186-92. (Pubitemid 29022513)
6. Tourdot S, Mathie S, Hussell T, et al. Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization. Clin Exp Allergy 2008;38:1016-24. (Pubitemid 351725848)
7. Peebles RS Jr, Sheller JR, Collins RD, et al. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice. J Med Virol 2001;63:178-88. (Pubitemid 32142275)
8. Hashimoto K, Graham BS, Ho SB, et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am J Respir Crit Care Med 2004;170:306-12. (Pubitemid 38971416)
9. Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003;111:1293-8. (Pubitemid 36683685)
10. Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108:430-8. (Pubitemid 32881066)
11. Gaffen SL. Recent advances in the IL-17 cytokine family. Curr Opin Immunol 2011;23:613-19.
12. Peck A, Mellins ED. Precarious balance: Th17 cells in host defense. Infect Immun 2010;78:32-8.
13. Schnyder-Candrian S, Togbe D, Couillin I, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006;203:2715-25. (Pubitemid 44833347)
14. Ballantyne SJ, Barlow JL, Jolin HE, et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 2007;120:1324-31. (Pubitemid 350216590)
15. Murdoch JR, Lloyd CM. Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cells. Am J Respir Crit Care Med 2010;182:464-76.
16. McKinley L, Alcorn JF, Peterson A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008;181:4089-97.
17. Wakashin H, Hirose K, Maezawa Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008;178:1023-32.
18. Wilson RH, Whitehead GS, Nakano H, et al. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med 2009;180:720-30.
19. http://www.clinicaltrials.gov/ct2/show/NCT01199289?term= amg+827+asthma&rank=1. 4-5-0012 (accessed 6 Jul 2012). Search terms AMG 827 and AIN 457.
20. Graham BS, Perkins MD, Wright PF, et al. Primary respiratory syncytial virus infection in mice. J Med Virol 1988;26:153-62.
21. Eustace A, Smyth LJ, Mitchell L, et al. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest 2011;139:1089-100.
22. Hamada H, Garcia-Hernandez ML, Reome JB, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 2009;182:3469-81.
23. O' Brien RL, Roark CL, Born WK. IL-17-producing gammadelta T cells. Eur J Immunol 2009;39:662-6.
24. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-32. (Pubitemid 41541790)
25. Chen Y, Langrish CL, McKenzie B, et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006;116:1317-26.
26. Hoeve MA, Savage ND, de Boer T, et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 2006;36:661-70.
27. Jewell NA, Vaghefi N, Mertz SE, et al . Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 2007;81:9790-800. (Pubitemid 350067683)
28. Guo B, Chang EY, Cheng G. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest 2008;118:1680-90. (Pubitemid 351632372)
29. Hirahara K, Ghoreschi K, Laurence A, et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev 2010;21:425-34.
30. Zhou L, Ivanov II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8:967-74. (Pubitemid 47300011)
31. Shinohara ML, Kim JH, Garcia VA, et al. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 2008;29:68-78.
32. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937-47. (Pubitemid 40524463)
33. Brooks GD, Buchta KA, Swenson CA, et al . Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. Am J Respir Crit Care Med 2003;168:1091-4. (Pubitemid 37338938)
34. Lajoie S, Lewkowich IP, Suzuki Y, et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 2010;11:928-35.
35. Mukherjee S, Lindell DM, Berlin AA, et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011;179:248-58.
36. Bera MM, Lu B, Martin TR, et al. Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins. J Immunol 2011;187:4245-55.
37. Kudo M, Melton AC, Chen C, et al. IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med 2012;18:547-54.
38. Barlow JL, Flynn RJ, Ballantyne SJ, et al. Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity. Clin Exp Allergy 2011;41:1447-55.
39. Essilfie AT, Simpson JL, Dunkley ML, et al. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 2012;67:588-99.